This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Belcaro, G. Articles by Leon, M. Search for Related Content PubMed PubMed Citation Articles by Belcaro, G. Articles by Leon, M. Pubmed/NCBI databases Medline Plus Health Information Diabetic Nerve Problems Social Bookmarking                         What's this?

Skin Flow The Venoarteriolar Response and Capillary Filtration in Diabetics. A 3-year Follow-Up

Microcirculation Laboratory, Cardiovascular Institute, Dir. Prof. A. Barsotti, Chieti University, Chieti, Italy, Irvine Cardiovascular Laboratory, St. Mary's Hospital, London, England

A.N. Nicolaides

Irvine Cardiovascular Laboratory, St. Mary's Hospital, London, England

N. Volteas

Irvine Cardiovascular Laboratory, St. Mary's Hospital, London, England

M. Leon

Irvine Cardiovascular Laboratory, St. Mary's Hospital, London, England

Resting skin blood flow (RF) and the venoarteriolar response (VAR = the vasocontrictor response on standing) have been studied in 100 patients with dia betic neuropathy, in 100 diabetics without neuropathy, and in 100 normal sub jects by laser Doppler flowmetry. Capillary filtration was also studied with strain gauge plethysmography. The authors followed up these patients by evaluating their microcirculation again after three years.

At the beginning of the study in patients with neuropathy, RF and capillary filtration were increased. The VAR and the microangiopathy index (MI = VAR/RF) were reduced in all diabetics, to a greater extent to those with neuropathy.

After three years the authors observed an increase in capillary filtration as sociated with a further impairment in VAR and MI, suggesting progression of microangiopathy in both groups of diabetics.

These results suggest that the postural control of blood flow in the skin of the foot is impaired in diabetic microangiopathy, particularly in neuropathics. Increased skin blood flow and capillary filtration and the impaired venoarterio lar response cause edema and may contribute to the thickening of capillary base ment membranes and the progressive evolution of diabetic microangiopathy.

Angiology, Vol. 43, No. 6, 490-495 (1992)
DOI: 10.1177/000331979204300606


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Belcaro, M. Rosaria Cesarone, A. Ledda, M. Cacchio, I. Ruffini, A. Ricci, E. Ippolito, A. Di Renzo, M. Dugall, M. Corsi, et al. O-({beta}-Hydroxyethyl)-Rutosides Systemic and Local Treatment in Chronic Venous Disease and Microangiopathy: An Independent Prospective Comparative Study Angiology, March 1, 2008; 59(1_suppl): 7S - 13S. [Abstract] [PDF]

				G. Belcaro, M. R. Cesarone, A. Ledda, M. Cacchio, I. Ruffini, A. Ricci, E. Ippolito, A. Di Renzo, M. Dugall, M. Corsi, et al. 5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-({beta}-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry Angiology, March 1, 2008; 59(1_suppl): 14S - 20S. [Abstract] [PDF]

				M. Rosaria Cesarone, G. Belcaro, S. Errichi, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al. Microcirculatory Effects of Viatromb(R) Spray Gel Heparin in Chronic Venous Insufficiency: Evaluation of TcPO2 and PCO2--A Product Evaluation Study Angiology, April 1, 2007; 58(1S): 21S - 26S. [Abstract] [PDF]

				M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al. Rapid Relief of Signs/Symptoms in Chronic Venous Microangiopathy With Pycnogenol(R): A Prospective, Controlled Study Angiology, October 1, 2006; 57(5): 569 - 576. [Abstract] [PDF]

				G. Belcaro, M. R. Cesarone, A. Ricci, U. Cornelli, P. Rodhewald, A. Ledda, A. Di Renzo, S. Stuard, M. Cacchio, G. Vinciguerra, et al. Control of Edema in Hypertensive Subjects Treated With Calcium Antagonist (Nifedipine) or Angiotensin-Converting Enzyme Inhibitors With Pycnogenol Clinical and Applied Thrombosis/Hemostasis, October 1, 2006; 12(4): 440 - 444. [Abstract] [PDF]

				M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al. Improvement of Diabetic Microangiopathy With Pycnogenol(R): A Prospective, Controlled Study Angiology, August 1, 2006; 57(4): 431 - 436. [Abstract] [PDF]

				G. Belcaro, M. R. Cesarone, B. M. Errichi, A. Ledda, A. Di Renzo, S. Stuard, M. Dugall, L. Pellegrini, G. Gizzi, P. Rohdewald, et al. Diabetic Ulcers: Microcirculatory Improvement and Faster Healing With Pycnogenol Clinical and Applied Thrombosis/Hemostasis, July 1, 2006; 12(3): 318 - 323. [Abstract] [PDF]

				M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al. Comparison of Pycnogenol(R) and Daflon(R) in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 205 - 212. [Abstract] [PDF]

				M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, A. Di Renzo, I. Ruffini, G. Gizzi, E. Ippolito, et al. Venoruton(R) vs Daflon(R): Evaluation of Effects on Quality of Life in Chronic Venous Insufficiency Angiology, March 1, 2006; 57(2): 131 - 138. [Abstract] [PDF]

				G. Belcaro, M. R. Cesarone, B. M. Errichi, A. Ledda, A. Di Renzo, S. Stuard, M. Dugall, L. Pellegrini, P. Rohdewald, E. Ippolito, et al. Venous Ulcers: Microcirculatory Improvement and Faster Healing with Local Use of Pycnogenol(R) Angiology, November 1, 2005; 56(6): 699 - 705. [Abstract] [PDF]

				G. Belcaro, M. R. Cesarone, G. Vinciguerra, A. Ledda, M. Dugall, A. Di Renzo, S. Stuard, A. Ricci, M. Cacchio, E. Ippolito, et al. A Plaster Combining Diclofenac and Heparin: Microcirculatory Evaluation in 2 Models of High-Perfusion Microangiopathy Angiology, November 1, 2005; 56(6): 707 - 713. [Abstract] [PDF]

				M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, M. Dugall, et al. HR, 0-(Beta-Hydroxyethyl)-Rutosides; (Venoruton(R)): Rapid Relief of Signs/Symptoms in Chronic Venous Insufficiency and Microangiopathy: A Prospective, Controlled Study Angiology, March 1, 2005; 56(2): 165 - 172. [Abstract] [PDF]

				M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, A. Di Renzo, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al. HR, 0-(Beta-Hydroxyethyl)-Rutosides, in Comparison with Diosmin+Hesperidin in Chronic Venous Insufficiency and Venous Microangiopathy: An Independent, Prospective, Comparative Registry Study Angiology, January 1, 2005; 56(1): 1 - 8. [Abstract] [PDF]

				G. Belcaro, M. R. Cesarone, P. Bavera, A. Ricci, S. Renton, M. Leon, E. Ippolito, M. Dugall, and G. Acerbi HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in Chronic Venous Disease and Microangiopathy: An Independent Prospective, Controlled, Randomized Trial Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 139 - 145. [Abstract] [PDF]

				L. Incandela, G. Belcaro, S. Renton, M. T. DeSanctis, M. R. Cesarone, P. Bavera, E. Ippolito, M. Bucci, M. Griffin, G. Geroulakos, et al. HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1_suppl): S7 - S10. [Abstract] [PDF]

				L. Incandela, M. R. Cesarone, M. T. DeSanctis, G. Belcaro, M. Dugall, and G. Acerbi Treatment of Diabetic Microangiopathy and Edema with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Prospective, Placebo-Controlled, Randomized Study Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1_suppl): S11 - S15. [Abstract] [PDF]

				M. R. Cesarone, L. Incandela, M. T. DeSanctis, G. Belcaro, M. Dugall, and G. Acerbi Variations in Plasma Free Radicals in Patients with Venous Hypertension with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized Trial Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1_suppl): S25 - S28. [Abstract] [PDF]

				G. Yosipovitch, J. Schneiderman, D. J. van Dyk, A. Chetrit, G. Milo, and G. Boner Impairment of the Postural Venoarteriolar Response in Young Type 1 Diabetic Patients: A Study by Laser Doppler Flowmetry Angiology, July 1, 1996; 47(7): 687 - 691. [Abstract] [PDF]